Oncotelic Therapeutics, Inc. Restructuring Costs
Oncotelic Therapeutics, Inc. (OTLC) reported Restructuring Costs of $0 for the 12-month period ending 2010-12-31, per its 10-K filed 2013-03-15.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2013-03-15
- Oncotelic Therapeutics, Inc. restructuring costs for fiscal 2010 was $0.00.
| Period end | Restructuring Costs 12 month |
|---|---|
| 2010-12-31 | $0.00 10-K · filed 2013-03-15 |